GMR Solutions earnings release, June 1, 2026
GMR Solutions Inc. Reports First Quarter 2026 Financial Results and Establishes Full Year 2026 Guidance
LEWISVILLE, Texas (June 1, 2026) — GMR Solutions Inc. (“GMR” or the “Company”) (NYSE: GMRS), the nation’s largest provider of emergency medical services (“EMS”), today announced financial results for the first quarter ended March 31, 2026, and full year 2026 financial guidance.
First Quarter 2026 Financial Highlights
“GMR’s first-quarter performance reflects the strength of our strategy and the discipline with which we are executing it,” said Nick Loporcaro, Chairman and Chief Executive Officer of GMR. “Our teams continue to deliver solid top-line and net income growth, while staying focused on our core mission-critical services. Taken together, these results reinforce our confidence that GMR has the right foundation, the right financial discipline, and the right growth opportunities to create long-term value and expand our services.”
Key Financials
¹
Business Metrics
Full Year 2026 Financial Guidance
GMR is establishing the following guidance for the full year 2026:
²
Webcast and Conference Call Details
The Company will host a conference call tomorrow, June 2, 2026, at 10 a.m. Eastern Time. Investors can access the live call by joining the following link https://events.q4inc.com/attendee/146682024.
An archived webcast of the event will be available on the “Events & Presentations” section of the GMR website at https://investors.globalmedicalresponse.com/. The Company has posted supplemental information on the first quarter 2026 results that it will reference during the conference call. The supplemental information can be found under the “Financials” tab on the Company’s investor relations page. Following the live event, replays will be available via webcast for one year at https://investors.globalmedicalresponse.com/.
About Global Medical Response
GMR is the nation’s largest provider of EMS, delivering EMS and other essential out-of-hospital care in rural and urban communities that represent more than 60% of the U.S. population. As the only national, fully integrated, air and ground EMS provider, GMR operates in approximately 1,400 counties across the country. A recognized innovator, GMR develops new solutions to meet evolving industry needs and expand access to high-quality care. With roughly 34,000 team members, GMR supports roughly 5.5 million patient encounters annually and performs a critical care intervention every 88 seconds. Its family of solutions includes ambulance EMS provider American Medical Response, as well as multiple air EMS organizations including Air Evac Lifeteam, REACH Air Medical Services, Guardian Flight, Med-Trans Corporation, and AirMed International.
We may use our website (www.globalmedicalresponse.com), Facebook page (www.facebook.com/GlobalMedicalResponse), X (Twitter) (www.x.com/GMR_Social), LinkedIn (www.linkedin.com/company/Global-Medical-Response), and Instagram (www.instagram.com/Global_Medical_Response), accounts as channels of distribution of company information. The information we post through these channels may be deemed material. Accordingly, investors should monitor these channels, in addition to following our press releases, Securities and Exchange Commission (“SEC”) filings and public conference calls and webcasts. In addition, you may automatically receive email alerts and other information about the Company when you enroll your email address by visiting the “Investor Email Alerts” section of our website at https://investors.globalmedicalresponse.com/resources/investor-email-alerts/default.aspx. The contents of our website, any alerts and social media channels are not, however, a part of this press release.
Financial statements
Income Statement
Three Months Ended — Key Financials (in millions)
| Three Months Ended – March 31 – 2026 – (Unaudited) | Three Months Ended – March 31 – 2025 – (Unaudited) | % | |
|---|---|---|---|
| Net revenue | 1,457,576 | 1,367,407 | 6.6% |
Income Statement
Range for the year ending — GMR is establishing the following guidance for the full year 2026: (in millions)
| Range for the year ending – December 31, 2026 – Low | Range for the year ending – December 31, 2026 – High | |
|---|---|---|
| Net revenue | 5,890 | 6,180 |
| Adjusted EBITDA(2) | 1,135 | 1,195 |
| Cash used for net capital expenditures and aircraft financing as a percent of net revenue | 5.1% | 5.3% |
Income Statement
Three Months Ended — )
| Three Months Ended – March 31, – 2026 | Three Months Ended – March 31, – 2025 | ||
|---|---|---|---|
| Net revenue | 1,457,576 | 1,367,407 | |
| Operating expenses: | Employee wages, benefits and taxes | 770,006 | 734,758 |
| Operating expenses: | Maintenance, fuel and other direct expenses | 118,620 | 111,811 |
| Operating expenses: | Insurance expense | 42,979 | 33,652 |
| Operating expenses: | Other operating expenses | 228,094 | 215,806 |
| Operating expenses: | Depreciation and amortization | 75,367 | 75,127 |
| Operating expenses: | Impairment of assets held for sale and other investments | 14,100 | |
| Operating expenses: | Acquisition, integration and other charges | 3,612 | 4,301 |
| Operating expenses: | Total operating expenses | 1,238,678 | 1,189,555 |
| Operating expenses: | Operating income | 218,898 | 177,852 |
| Operating expenses: | Interest expense, net | 83,174 | 113,685 |
| Operating expenses: | Equity in (earnings) losses of unconsolidated affiliates | -463 | -2,302 |
| Operating expenses: | Other (income) loss, net | -6,344 | -922 |
| Operating expenses: | Net income (loss) before income taxes | 142,531 | 67,391 |
| Operating expenses: | Income tax (benefit) expense | 36,195 | 29,367 |
| Operating expenses: | Net income (loss) | 106,336 | 38,024 |
| Net income (loss) available to common stockholders per share: | Basic | 0.92 | -0.03 |
| Net income (loss) available to common stockholders per share: | Diluted | 0.28 | -0.03 |
| Weighted-average common shares outstanding: | Basic | 45,836,749 | 45,551,279 |
| Weighted-average common shares outstanding: | Diluted | 149,275,141 | 45,551,279 |
| Comprehensive income (loss): | Net income (loss) | 106,336 | 38,024 |
| Other comprehensive income (loss) | Unrealized holding gains (losses) on investments | -524 | 468 |
| Other comprehensive income (loss) | Deferred income tax benefit (expense), net | 116 | -104 |
| Other comprehensive income (loss) | Total other comprehensive income (loss), net of income tax | -408 | 364 |
| Other comprehensive income (loss) | Comprehensive income (loss) | 105,928 | 38,388 |
Income Statement
Three Months Ended — The following table reconciles net income to EBITDA and Adjusted EBITDA:
| Three Months Ended – March 31, – 2026 | Three Months Ended – March 31, – 2025 | 2026 v. – 2025 Change | |
|---|---|---|---|
| Net income (loss) | 106,336 | 38,024 | 179.7% |
| Interest expense, net | 83,174 | 113,685 | -26.8% |
| Income tax provision (benefit) | 36,195 | 29,367 | 23.3% |
| Depreciation and amortization | 75,367 | 75,127 | 0.3% |
| EBITDA | 301,072 | 256,203 | 17.5% |
| Management fees(1) | 2,977 | 2,705 | 10.1% |
| Stock-based compensation(2) | -91 | 2,605 | -103.5% |
| Professional fees and other expenses for non-recurring matters(3) | 6,911 | 4,554 | 51.8% |
| Debt refinancing fees paid to (received from) third parties(4) | 320 | 383 | -16.4% |
| Impairment of assets held for sale and other investments(5) | 14,100 | -100.0% | |
| (Gain) loss on divestiture of businesses(6) | -1,422 | -100.0% | |
| Realized and unrealized (gain) loss, net(7) | -5,674 | 1,235 | -559.4% |
| Equity method investment (income) loss(8) | -463 | -2,302 | -79.9% |
| Adjusted EBITDA | 305,052 | 278,061 | 9.7% |
Balance Sheet
December 31, — (Amounts in thousands)
| March 31, – 2026 – (unaudited) | December 31, – 2025 | ||
|---|---|---|---|
| Current assets: | Cash and cash equivalents | 426,092 | 609,349 |
| Current assets: | Insurance collateral | 74,396 | 78,608 |
| Current assets: | Accounts receivable, net | 1,159,661 | 1,094,814 |
| Current assets: | Spare parts, medical supplies and fuel | 123,772 | 115,725 |
| Current assets: | Prepaid expenses | 75,808 | 105,014 |
| Current assets: | Other current assets | 135,098 | 128,571 |
| Current assets: | Total current assets | 1,994,827 | 2,132,081 |
| Current assets: | Property and equipment, net of accumulated depreciation of $1,269,762 and $1,223,603 at March 31, 2026 and December 2025, respectively | 1,364,127 | 1,361,278 |
| Current assets: | Operating right-of-use assets | 207,786 | 203,258 |
| Current assets: | Finance right-of-use assets | 88,730 | 85,030 |
| Current assets: | Intangible assets, net | 1,188,075 | 1,204,237 |
| Current assets: | Goodwill | 2,180,581 | 2,180,581 |
| Current assets: | Other assets | 316,509 | 315,580 |
| Current assets: | Total assets | 7,340,635 | 7,482,045 |
| Current liabilities: | Accounts payable | 65,822 | 60,047 |
| Current liabilities: | Accrued wages, benefits and taxes | 264,812 | 339,710 |
| Current liabilities: | Accrued interest | 91,504 | 75,655 |
| Current liabilities: | Other accrued liabilities | 423,468 | 363,160 |
| Current liabilities: | Current portion of lease obligations | 80,562 | 78,717 |
| Current liabilities: | Current portion of long-term debt | 141,809 | 147,140 |
| Current liabilities: | Total current liabilities | 1,067,977 | 1,064,429 |
| Current liabilities: | Operating lease obligations | 174,179 | 171,880 |
| Current liabilities: | Finance lease obligations | 79,314 | 74,943 |
| Current liabilities: | Long-term debt | 4,894,435 | 4,898,769 |
| Current liabilities: | Deferred income taxes | 208,947 | 209,067 |
| Current liabilities: | Insurance reserves | 310,619 | 312,069 |
| Current liabilities: | Other long-term liabilities | 100,026 | 101,593 |
| Current liabilities: | Total liabilities | 6,835,497 | 6,832,750 |
| Mezzanine equity: | Redeemable preferred stock | 292,469 | 445,140 |
| Mezzanine equity: | Total mezzanine equity | 292,469 | 445,140 |
Cash Flow
Three Months Ended — (Amounts in thousands, unaudited)
| Three Months Ended – March 31, – 2026 | Three Months Ended – March 31, – 2025 | ||
|---|---|---|---|
| Cash flows from operating activities: | Net income (loss) | 106,336 | 38,024 |
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities | Depreciation and amortization | 75,367 | 75,127 |
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities | Amortization of deferred financing costs and debt discount | 2,389 | 4,094 |
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities | Paid-in-kind interest on long-term debt | 7,757 | |
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities | Impairment of assets held for sale and other investments | 14,100 | |
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities | (Gain) loss on divestiture of businesses | -1,422 | |
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities | Stock-based compensation expense | -91 | 520 |
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities | Liability classified stock awards | 2,085 | |
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities | Loss (gain) on disposal of property and equipment | 1,076 | 4,105 |
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities | Unrealized loss (gain) on marketable equity securities | 1,227 | 1,235 |
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities | Deferred income taxes | -4 | -1 |
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities | Other, net | -7,364 | -2,302 |
| Changes in assets and liabilities, net of effects of acquisitions | Accounts receivable, net | -64,847 | -61,631 |
| Changes in assets and liabilities, net of effects of acquisitions | Accounts payable | 5,775 | 3,050 |
| Changes in assets and liabilities, net of effects of acquisitions | Accrued wages, benefits and taxes | -73,169 | -34,704 |
| Changes in assets and liabilities, net of effects of acquisitions | Accrued interest | 15,849 | 65,712 |
| Changes in assets and liabilities, net of effects of acquisitions | Accrued liabilities | 54,375 | 47,643 |
| Changes in assets and liabilities, net of effects of acquisitions | Other assets and liabilities, net | 11,824 | 25,951 |
| Changes in assets and liabilities, net of effects of acquisitions | Net cash provided by (used in) operating activities | 128,743 | 189,343 |
| Cash flows from investing activities: | Proceeds from divestiture of businesses | 6,422 | |
| Cash flows from investing activities: | Proceeds from asset disposals related to sales and insurance recoveries | 1,199 | 265 |
| Cash flows from investing activities: | Purchases of property and equipment | -64,138 | -52,458 |
| Cash flows from investing activities: | Net change in investments held as insurance collateral | -660 | -734 |
| Cash flows from investing activities: | Purchases of marketable securities | -25,878 | -10,150 |
| Cash flows from investing activities: | Sales and maturities of marketable securities | 24,819 | 12,852 |
| Cash flows from investing activities: | Other investing activities, net | 13,200 | -4,613 |
| Cash flows from investing activities: | Net cash provided by (used in) investing activities | -51,458 | -48,416 |
| Cash flows from financing activities: | Payments on finance lease obligations | -3,016 | -3,493 |
| Cash flows from financing activities: | Principal payments on long-term debt | -39,491 | -36,084 |
| Cash flows from financing activities: | Proceeds from issuance of long-term debt | 27,681 | 10,000 |
| Cash flows from financing activities: | (Redemption) issuance of redeemable preferred stock | -249,994 | |
| Cash flows from financing activities: | Proceeds from issuance of shares under stock award plan, net of cash taxes paid | 498 | |
| Cash flows from financing activities: | Net cash provided by (used in) financing activities | -264,820 | -29,079 |
| Cash flows from financing activities: | (Decrease) increase in cash, cash equivalents, restricted cash and restricted cash equivalents | -187,535 | 111,848 |
| Cash flows from financing activities: | Cash and cash equivalents, beginning of period (including restricted cash and restricted cash equivalents of $14.8 million and $16.6 million, respectively) | 624,229 | 368,902 |
| Cash flows from financing activities: | Cash and cash equivalents, end of period (including restricted cash and restricted cash equivalents of $10.6 million and $15.6 million, respectively) | 436,694 | 480,750 |
| Supplemental disclosure of cash flow information | Equipment (primarily aircraft) additions financed with the issuance of debt | $— | 4,131 |
| Cash paid (received) during the period for: | Interest | 76,324 | 36,126 |
| Cash paid (received) during the period for: | Income taxes, net of refunds received | -878 | 1,099 |
Full release
Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect our current views with respect to, among other things, our operations and financial performance. Forward-looking statements include all statements that are not historical facts , including statements related to our ability to create long-term value and expand our services and statements regarding our financial guidance. These forward-looking statements may relate to matters which include, but are not limited to, industries, business strategy, goals and expectations concerning our market position, future operations, margins, profitability, capital expenditures, liquidity and capital resources and other financial and operating information. In some cases, you can identify these forward-looking statements by the use of words such as “anticipate,” “assume,” “believe,” “can,” “continue,” “could,” “estimate,” “expect,” “foreseeable,” “future,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “seek,” “should,” “will,” “would,” the negative version of these words, or similar terms and phrases.
The forward-looking statements are based on management’s current expectations and are not guarantees of future performance. The forward-looking statements are subject to various risks, uncertainties, assumptions or changes in circumstances that are difficult to predict or quantify. Our expectations, beliefs and projections are expressed in good faith and we believe there is a reasonable basis for them. However, there can be no assurance that management’s expectations, beliefs, and projections will result or be achieved. Actual results may differ materially from these expectations due to changes in global, regional or local economic, business, competitive, market, regulatory and other factors, many of which are beyond our control. We believe that these factors include but are not limited to the following:³
... (truncated)lings with the SEC, including the information under the captions “Risk Factors” in GMR’s final prospectus (the “IPO Prospectus”) in connection with our initial public offering (the “IPO”), filed with the SEC and dated May 12,⁴
2026, as well as GMR’s subsequent other filings with the SEC from time to time. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, our actual results may vary in material respects from those projected in these forward-looking statements.
Any forward-looking statement made by us herein speaks only as of the date of this press release and are expressly qualified in their entirety by the cautionary statements included herein. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We may not actually achieve the plans, intentions, or expectations disclosed in our forward-looking statements and you should not place undue reliance on our forward-looking statements. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures, investments, or other strategic transactions we may make. We undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by any applicable securities laws. For additional information on these and other factors that could cause GMR’s actual results to differ materially from expected results, please see our filings with the SEC, which are accessible on the SEC’s website at www.sec.gov and on the “Investor Relations” tab of our website.
Non-GAAP Financial Measures
This press release contains “non-GAAP financial measures,” which are financial measures that either exclude or include amounts that are not excluded or included in the most directly comparable measures calculated and presented in accordance with GAAP. Specifically, we make use of the non-GAAP financial measures “EBITDA” and “Adjusted EBITDA.”
We provide non-GAAP financial information to enhance the understanding of our GAAP financial information and it should be considered by the reader in addition to, but not instead of, the financial statements prepared in accordance with GAAP. Each non-GAAP financial measure is presented along with the corresponding GAAP measure so as not to imply that more emphasis should be placed on the non-GAAP measure. We believe that providing these non-GAAP measures in addition to the GAAP measures allows management, investors and other users of our financial information to more fully and accurately assess performance. The non-GAAP financial information presented may be determined or calculated differently by other companies and may not be directly comparable to that of other companies.
We define EBITDA as net income (loss) before interest expense, net, income tax provision (benefit), and depreciation and amortization. We define Adjusted EBITDA as EBITDA, as further adjusted to exclude management fees, non-cash stock-based compensation, professional fees and other expenses for non-recurring matters, debt financing fees paid to (received from) third parties and certain other items that we do not consider indicative of our ongoing operating performance.
Management uses EBITDA and Adjusted EBITDA to supplement GAAP measures of performance in the evaluation of the effectiveness of our business strategies, to make budgeting decisions, to establish and award discretionary annual incentive compensation, to report compliance with certain covenants in our debt agreements and to compare our performance against that of peer companies using similar measures. Moreover, we present EBITDA and Adjusted EBITDA because we believe that investors consider them to be important supplemental measures of our performance and believe these measures are frequently used by securities analysts, investors and other interested parties in the evaluation of companies in our industry.
Adjusted EBITDA is an analytical indicator used by management and the healthcare industry to evaluate company performance, allocate resources and measure leverage. Adjusted EBITDA should not be considered in isolation or as an alternative to net income (loss), cash flows from operations, investing or financing activities, or other financial statement data presented in the unaudited condensed consolidated financial statements as indicators of financial performance. Because Adjusted EBITDA is not a measure determined in accordance with GAAP and is thus susceptible to varying calculations, Adjusted EBITDA as presented may not be comparable to other similarly titled measures of other companies and may not be comparable to similarly titled measures used in debt compliance calculations. Net income (loss) is the financial measure calculated and presented in accordance with GAAP that is most comparable to Adjusted EBITDA, as defined.
GMR Contacts:
Media Contact:
Kirsten Gurmendi
Public Relations Director, GMR Solutions Inc. media@gmr.net
877.418.2980
Investor Contact:
Krister Sorensen
Vice President, Investor Relations, GMR Solutions Inc.
Investor.relations@gmr.net
⁵
GMR Solutions Inc. and Subsidiaries
Condensed Consolidated Balance Sheets
March 31, 2026 and December 31, 2025
(Amounts in thousands)
⁶
GMR Solutions Inc. and Subsidiaries
Consolidated Statements of Operations
For the three months ended March 31, 2026 and 2025
(
Amounts in thousands, except share and per share amounts, unaudited)
⁷
GMR Solutions Inc. and Subsidiaries
Consolidated Statements of Cash Flows
For the three months ended March 31, 2026 and 2025
(Amounts in thousands, unaudited)
⁸
GMR Solutions Inc. and Subsidiaries
Reconciliation of EBITDA and Adjusted EBITDA
For the three months ended March 31, 2026 and 2025
(Amounts in thousands, unaudited)... (truncated)econciles net income to EBITDA and Adjusted EBITDA:
⁹
¹⁰